$0.3746
-0.0058-1.52%
Last update: Oct 29, 6:37 PM
Evogene Ltd
EVGNNASDAQ
Evogene (EVGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.27 | $-0.27 | $-0.26 | $-0.41 |
| Actual | $-0.13 | $-0.60 | $-0.61 | $-0.31 |
| Surprise | +51.8% | -122.2% | -134.6% | +24.4% |
| Revenue | ||||
| Estimate | $325000 | $350000 | $275000 | $650000 |
| Actual | $347000 | $334000 | $314000 | $312000 |
| Surprise | +6.77% | -4.57% | +14.2% | -52.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.19 | $-0.20 |
| Revenue | ||
| Consensus | $366000 | $390000 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 18, 2026 | $-0.13 | $-0.27 | 51.8 % |
| Q1 | May 20, 2026 | $-0.60 | $-0.27 | -122.2 % |
| Q4 | Mar 5, 2026 | $-0.61 | $-0.26 | -134.6 % |
| Q3 | Nov 20, 2025 | $-0.31 | $-0.41 | 24.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 18, 2026 | $347.00K | $325.00K | 6.77 % |
| Q1 | May 20, 2026 | $334.00K | $350.00K | -4.57 % |
| Q4 | Mar 5, 2026 | $314.00K | $275.00K | 14.2 % |
| Q3 | Nov 20, 2025 | $312.00K | $650.00K | -52.0 % |
